Cited by 81

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth

McKee, Alastair M., Kirkup, Benjamin M., Madgwick, Matthew, Fowler, Wesley J., Price, Christopher A., Dreger, Sally A., Ansorge, Rebecca, Makin, Kate A., Caim, Shabhonam, Le Gall, Gwenaelle, Paveley, Jack, Leclaire, Charlotte, Dalby, Matthew, Alcon-Giner, Cristina, Andrusaite, Anna, Feng, Tzu-Yu, Di Modica, Martina, Triulzi, Tiziana, Tagliabue, Elda, Milling, Simon W.F., Weilbaecher, Katherine N., Rutkowski, Melanie R., Korcsmáros, Tamás, Hall, Lindsay J., Robinson, Stephen D.·2021·iScience

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.isci.2021.103012

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 14 references

Research works printed but not linked: 79

  1. Allegrezza, 2016, Trametinib drives T-cell-dependent control of KRAS-mutated tumors by inhibiting pathological myelopoiesis, Cancer Res., 76, 6253, 10.1158/0008-5472.CAN-16-1308 · DOI
  2. Aminov, 2010, A brief history of the antibiotic era: lessons learned and challenges for the future, Front Microbiol., 1, 134, 10.3389/fmicb.2010.00134 · DOI · Paper page
  3. Aponte-Lopez, 2018, Mast cell, the neglected member of the tumor microenvironment: role in breast cancer, J. Immunol. Res., 2018, 2584243
  4. Appleyard, 2011, Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer, Am. J. Physiol. Gastrointest. Liver Physiol., 301, G1004, 10.1152/ajpgi.00167.2011 · DOI
  5. Becattini, 2016, Antibiotic-induced changes in the intestinal microbiota and disease, Trends Mol. Med., 22, 458, 10.1016/j.molmed.2016.04.003 · DOI · Paper page
  6. Becht, 2018, Dimensionality reduction for visualizing single-cell data using UMAP, Nat. Biotechnol., 37, 38, 10.1038/nbt.4314 · DOI · Paper page
  7. Benito, 2017, Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome, Oncotarget, 8, 106693, 10.18632/oncotarget.21601 · DOI
  8. Boyd, 2007, Mammographic density and the risk and detection of breast cancer, N. Engl. J. Med., 356, 227, 10.1056/NEJMoa062790 · DOI
  9. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394
  10. Buchfink, 2015, Fast and sensitive protein alignment using DIAMOND, Nat. Methods, 12, 59, 10.1038/nmeth.3176 · DOI · Paper page
  11. Buchta Rosean, 2019, Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer, Cancer Res., 79, 3662, 10.1158/0008-5472.CAN-18-3464 · DOI
  12. Bush, 2016, β-Lactams and β-lactamase inhibitors: an overview, Cold Spring Harb. Perspect. Med., 6, a025247, 10.1101/cshperspect.a025247 · DOI · Paper page
  13. Carmi, 2015, Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity, Nature, 521, 99, 10.1038/nature14424 · DOI
  14. Castagnoli, 2014, Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab, Cancer Res., 74, 6248, 10.1158/0008-5472.CAN-14-0983 · DOI
  15. Chen, 2018, fastp: an ultra-fast all-in-one FASTQ preprocessor, Bioinformatics, 34, i884, 10.1093/bioinformatics/bty560 · DOI · Paper page
  16. Correa-Oliveira, 2016, Regulation of immune cell function by short-chain fatty acids, Clin. Transl Immunol., 5, e73, 10.1038/cti.2016.17 · DOI · Paper page
  17. Croswell, 2009, Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection, Infect. Immun., 77, 2741, 10.1128/IAI.00006-09 · DOI
  18. De Zuani, 2018, Mast cells at the crossroads of microbiota and IBD, Eur. J. Immunol., 48, 1929, 10.1002/eji.201847504 · DOI
  19. DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016/j.ccr.2009.06.018 · DOI
  20. DiLillo, 2010, B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice, J. Immunol., 184, 4006, 10.4049/jimmunol.0903009 · DOI
  21. Dudeck, 2011, Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens, Immunity, 34, 973, 10.1016/j.immuni.2011.03.028 · DOI
  22. Edwards, 2014, Use of prophylactic postoperative antibiotics during surgical drain presence following mastectomy, Ann. Surg. Oncol., 21, 3249, 10.1245/s10434-014-3960-7 · DOI
  23. Ewens, 2005, Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma, Anticancer Res., 25, 3905
  24. Feyerabend, 2011, Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity, Immunity, 35, 832, 10.1016/j.immuni.2011.09.015 · DOI
  25. Franzosa, 2018, Species-level functional profiling of metagenomes and metatranscriptomes, Nat. Methods, 15, 962, 10.1038/s41592-018-0176-y · DOI · Paper page
  26. Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am. J. Pathol., 167, 835, 10.1016/S0002-9440(10)62055-X · DOI
  27. Guan, 2020, Gut microbiota profiling in patients with HER2-negative metastatic breast cancer receiving metronomic chemotherapy of capecitabine compared to those under conventional dosage, Front. Oncol., 10, 902, 10.3389/fonc.2020.00902 · DOI
  28. Han, 2018, Mapping the mouse cell atlas by microwell-seq, Cell, 172, 1091, 10.1016/j.cell.2018.02.001 · DOI · Paper page
  29. He, 2021, Changes of intestinal microflora of breast cancer in premenopausal women, Eur. J. Clin. Microbiol. Infect. Dis., 40, 503, 10.1007/s10096-020-04036-x · DOI
  30. He, 2016, Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice, Cancer Med., 5, 1292, 10.1002/cam4.696 · DOI
  31. Hothorn, 2008, Implementing a class of permutation tests: the coin package, J. Stat. Softw., 28, 1
  32. Huo, 2018, High mammographic density in women is associated with protumor inflammation, Breast Cancer Res., 20, 92, 10.1186/s13058-018-1010-2 · DOI
  33. Jones, 2014, Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery, Cochrane Database Syst. Rev., 9, CD005360
  34. Kelly, 2012, Microbiome and immunological interactions, Nutr. Rev., 70, S18, 10.1111/j.1753-4887.2012.00498.x · DOI
  35. Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36 · DOI · Paper page
  36. Lakritz, 2014, Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice, Int. J. Cancer, 135, 529, 10.1002/ijc.28702 · DOI
  37. Lechowski, 2013, Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells, Eur. J. Nutr., 52, 505, 10.1007/s00394-012-0353-1 · DOI
  38. Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 · DOI · Paper page
  39. Marchini, 2011, The human splice variant Delta16HER2 induces rapid tumor onset in a reporter transgenic mouse, PLoS One, 6, e18727, 10.1371/journal.pone.0018727 · DOI
  40. Mazurek, 1980, A binding site on mast cells and basophils for the anti-allergic drug cromolyn, Nature, 286, 722, 10.1038/286722a0 · DOI
  41. McCafferty, 2013, Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model, ISME J., 7, 2116, 10.1038/ismej.2013.106 · DOI · Paper page
  42. McCoy, 2017, Efficient genome-wide association in biobanks using topic modeling identifies multiple novel disease loci, Mol. Med., 23, 285, 10.2119/molmed.2017.00100 · DOI
  43. Metzger-Filho, 2013, Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX, J. Clin. Oncol., 31, 3083, 10.1200/JCO.2012.46.1574 · DOI
  44. Mullard, 2016, Tackling antimicrobial drug resistance, Nat. Rev. Drug Discov., 15, 375
  45. Naeini, 2019, Antitumor effects of curcumin: a lipid perspective, J. Cell Physiol, 234, 14743, 10.1002/jcp.28262 · DOI
  46. Oka, 2012, Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice, Lab. Invest., 92, 1472, 10.1038/labinvest.2012.116 · DOI
  47. Parhi, 2020, Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression, Nat. Commun., 11, 3259, 10.1038/s41467-020-16967-2 · DOI · Paper page
  48. Perez-Solis, 2016, Effects of the lifestyle habits in breast cancer transcriptional regulation, Cancer Cell Int, 16, 7, 10.1186/s12935-016-0284-7 · DOI
  49. Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI
  50. Ranganathan, 2018, Antibiotic prophylaxis after immediate breast reconstruction: the reality of its efficacy, Plast. Reconstr. Surg., 141, 865, 10.1097/PRS.0000000000004204 · DOI
  51. Rao, 2006, Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice, Cancer Res., 66, 7395, 10.1158/0008-5472.CAN-06-0558 · DOI
  52. Rasouli, 2017, In vitro activity of probiotic Lactobacillus reuteri against gastric cancer progression by downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor gene expression, J. Cancer Res. Ther., 13, 246, 10.4103/0973-1482.204897 · DOI
  53. Reikvam, 2011, Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression, PLoS One, 6, e17996, 10.1371/journal.pone.0017996 · DOI
  54. Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat. Rev. Immunol., 16, 341, 10.1038/nri.2016.42 · DOI · Paper page
  55. Rossini, 2006, Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice, Cancer Res., 66, 6219, 10.1158/0008-5472.CAN-05-4592 · DOI
  56. Schwarzer, 2019, Germ-free mice exhibit mast cells with impaired functionality and gut homing and do not develop food allergy, Front. Immunol., 10, 205, 10.3389/fimmu.2019.00205 · DOI
  57. Stuart, 2019, Comprehensive integration of single-cell data, Cell, 177, 1888, 10.1016/j.cell.2019.05.031 · DOI · Paper page
  58. Su, 2016, Antagonizing integrin beta3 increases immunosuppression in cancer, Cancer Res., 76, 3484, 10.1158/0008-5472.CAN-15-2663 · DOI
  59. Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209
  60. Tao, 2015, Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10, Eur. J. Immunol., 45, 999, 10.1002/eji.201444625 · DOI
  61. Teng, 2021, Exploring the impact of gut microbiota and diet on breast cancer risk and progression, Int. J. Cancer, 149, 494, 10.1002/ijc.33496 · DOI
  62. Tomayko, 1989, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol., 24, 148, 10.1007/BF00300234 · DOI · Paper page
  63. Trapnell, 2013, Differential analysis of gene regulation at transcript resolution with RNA-seq, Nat. Biotechnol., 31, 46, 10.1038/nbt.2450 · DOI · Paper page
  64. Tremaroli, 2012, Functional interactions between the gut microbiota and host metabolism, Nature, 489, 242, 10.1038/nature11552 · DOI · Paper page
  65. University of California Los Angeles. Department of Statistics., and Foundation for Open Access Statistics. Journal of statistical software. Foundation for Open Access Statistics. UCLA Statistics
  66. Varricchi, 2017, Are mast cells MASTers in cancer?, Front Immunol., 8, 424, 10.3389/fimmu.2017.00424 · DOI
  67. Velicer, 2004, Antibiotic use in relation to the risk of breast cancer, JAMA, 291, 827, 10.1001/jama.291.7.827 · DOI
  68. Velicer, 2006, Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States), Cancer Causes Control, 17, 307
  69. Viaud, 2013, The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide, Science, 342, 971, 10.1126/science.1240537 · DOI · Paper page
  70. Wagner, 2019, A single-cell atlas of the tumor and immune ecosystem of human breast cancer, Cell, 177, 1330, 10.1016/j.cell.2019.03.005 · DOI
  71. Wang, 2018, Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs, Innate Immun., 24, 40, 10.1177/1753425917741970 · DOI
  72. Wood, 2019, Improved metagenomic analysis with Kraken 2, Genome Biol., 20, 257, 10.1186/s13059-019-1891-0 · DOI
  73. Wu, 2020, Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study, Breast Cancer Res. Treat, 182, 451, 10.1007/s10549-020-05702-6 · DOI
  74. Wu, 2013, Dysbiosis signature of fecal microbiota in colorectal cancer patients, Microb. Ecol., 66, 462, 10.1007/s00248-013-0245-9 · DOI · Paper page
  75. Yuen, 2016, B lymphocytes and cancer: a love-hate relationship, Trends Cancer, 2, 747, 10.1016/j.trecan.2016.10.010 · DOI · Paper page
  76. Zagato, 2020, Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth, Nat. Microbiol., 5, 511, 10.1038/s41564-019-0649-5 · DOI · Paper page
  77. Zhang, 2016, Mast cell stabilisers, Eur. J. Pharmacol., 778, 158, 10.1016/j.ejphar.2015.05.071 · DOI
  78. Zhang, 2019, KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming, Exp. Cell Res, 379, 182, 10.1016/j.yexcr.2019.04.006 · DOI
  79. Zitvogel, 2017, Nutrition, inflammation and cancer, Nat. Immunol., 18, 843, 10.1038/ni.3754 · DOI · Paper page

Cited by

Sorted by citations

See all 81

Metadata

Authors
McKee, A. M., Kirkup, B. M., Madgwick, M., Fowler, W. J., Price, C. A., Dreger, S. A., Ansorge, R., Makin, K. A., Caim, S., Le Gall, G., Paveley, J., Leclaire, C., Dalby, M., Alcon-Giner, C., Andrusaite, A., Feng, T.-Y., Di Modica, M., Triulzi, T., Tagliabue, E., Milling, S. W. F., Weilbaecher, K. N., Rutkowski, M. R., Korcsmáros, T., Hall, L. J., & Robinson, S. D.
Venue
iScience
Publisher
Elsevier BV
Published
2021-09
Volume
24
Issue
9
Pages
103012
ISSN
2589-0042
Cited by
81
References
14
Language
en
Funders
  • Breast Cancer Now (2017NovPhD973)
  • Wellcome Trust (100974/C/13/Z)
  • Susan G Komen Breast Cancer Foundation
  • Biotechnology and Biological Sciences Research Council (BB/S50743X/1, BB/M011216/1, 20264, BBS/E/F/000PR10353, BBS/E/F/000PR10355, BB/R012490/1, BB/J014524/1, BB/J004529/1, BB/P016774/1)
  • UVA Cancer Center
  • Quadram Institute Bioscience
  • UK Research and Innovation
  • Cancer Research UK (C18281/A29019)
  • National Cancer Institute (P30CA44570, P30 CA44579)
  • Associazione Italiana per la Ricerca sul Cancro

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review